GNPX: Genprex Inc. Net Margin

Corporate emblem and logo of Genprex Inc. (GNPX)

The sales margin trajectory on the GURU.Markets system chart shows that Genprex, Inc. (GNPX) currently stands at 0.00. This trend depends on passing FDA trials for lung therapy while maintaining controlled R&D costs. Genprex, Inc. (GNPX) relies on the development of nanoparticles for gene delivery, while pipeline diversification between oncology and diabetes minimizes the business's regulatory risks.

genprex.com (GNPX) - Net Margin from 07/04/2022 to 11/19/2026

Genprex, Inc (GNPX) - metric breakdowns and financial figures

- market value and analyst target forecast:
Analysis of all company metrics:Genprex, Inc.
Finished products of Genprex Inc.

Sales margins determine the investment stability of the issuer by analyzing the remaining capital after all expenses. This metric measures the share of net profit in revenue, reflecting the actual efficiency of transforming income into free cash flow. The trend in target net margins allows for the differentiation of operational growth from one-time financial effects. For Genprex, Inc. (GNPX), this indicator is critical during the gene therapy development period. FDA approvals will serve as the catalyst for transitioning from the investment phase to the systemic monetization of products.

Key competitors

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)